诊断学理论与实践2023，Vol.22Issue(6)：534-540,7.DOI:10.16150/j.1671-2870.2023.06.004
我国支气管哮喘问卷应用现状及对策
Current status and strategies of asthma questionnaire application in China
摘要
Abstract
The prevalence of bronchial asthma in China is 4.2%,similar to other countries around the world,but the mortality rate of asthma in China is 36.7/100 000,which is four times as high as that of Japan and seven times as that of the United States.Therefore,It is urgent for China to strengthen the effectiveness of asthma management and minimize the risk of related deaths.Pivotal aspects of asthma management involve screening and assessing symptom control.Simple screening tools expedite rapid identification of patients who require more detailed assessment in primary medical care.Nu-merical tools like ACT and ACQ are widely used in clinical practice and clinical research.Categorical symptom control tools are extensively used in clinical studies.For example,asthma APGAR(Activities,Persistence,Triggers,Asthma medications,Response to therapy)questionnaire not only assists in assessing asthma,but also in enhancing treatment ad-herence,improving asthma control.Currently,some asthma questionnaires face limitations in their application in China,particularly concerning sociocultural factors,specific age groups,and heterogeneous phenotypes.More attention should be paid to individualized factors(age diverse,clinical phenotypes),and use of biomarkers and intelligent technologies in questionnaire design for enhancing management of asthma.关键词
哮喘/哮喘管理/控制问卷/患病率/咳嗽变异型咳嗽Key words
Asthma/Asthma management/Control questionnaires/Prevalence/Cough variant asthma分类
医药卫生引用本文复制引用
包婺平,林燕美,张旻..我国支气管哮喘问卷应用现状及对策[J].诊断学理论与实践,2023,22(6):534-540,7.基金项目
国家自然科学基金资助项目(82270027) （82270027）
上海市2020年度"科技创新行动计划"医学创新研究专项项目(20Y11902400,22ZR1449600) （20Y11902400,22ZR1449600）
上海市第一人民医院院级临床研究创新团队项目(CTCCR-2019B02,CTCCR-2021B07) （CTCCR-2019B02,CTCCR-2021B07）
2022年"中西医结合研究平台"建设项目(2022zxy006) （2022zxy006）
